Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 12 tags : Vaccine save search
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
Published: 2021-03-12 (Crawled : 17:00) - prnewswire.com
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
covid vaccine merge granted grant
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology
Published: 2021-03-12 (Crawled : 17:00) - biospace.com/
ANIX P | $3.17 0.32% 65K
|
Health Technology
|
| O: 30.51%
H: 2.12%
C: -12.94%
cancer vaccine patent ovarian cancer bioscience
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
Published: 2021-03-12 (Crawled : 17:00) - biospace.com/
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
covid vaccine merge granted grant
COVID-19 Vaccine News: Novavax Effective Against Variants; Sanofi/Translate Begin Early Trials
Published: 2021-03-12 (Crawled : 16:00) - biospace.com/
SNY | $46.05 -0.41% 940K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid vaccine trial covid-19
AccuShelf® Integrates COVID-19 Specific Vaccine Workflows to Help Healthcare Comply With COVID-19 Vaccine Storage and Tracking
Published: 2021-03-12 (Crawled : 15:00) - prnewswire.com
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
covid vaccine covid-19
COVID-19 Vaccine News: Novavax Effective Against Variants; Sanofi/Translate B...
Published: 2021-03-12 (Crawled : 15:00) - biospace.com/
SNY | $46.05 -0.41% 940K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid vaccine covid-19
Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us
Published: 2021-03-12 (Crawled : 14:21) - prnewswire.com
MRK | $125.44 -0.59% 2.5M
|
Health Technology
|
| O: -0.8%
H: 1.16%
C: 0.77%
REGN | $895.92 -0.29% 310K
|
Health Technology
|
| O: -0.63%
H: 1.03%
C: 0.96%
MRNA S | $104.6 0.71% 1.4M
|
Health Technology
|
| O: -4.58%
H: 3.51%
C: 2.2%
BNTX | $87.1 -0.9% 540K
|
Health Technology
|
| O: -3.18%
H: 3.97%
C: 3.97%
covid vaccine research covid-19
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
Published: 2021-03-12 (Crawled : 07:00) - globenewswire.com
TBIO | $0.386 2.2% 35K
|
Health Technology
|
| O: 4.53%
H: 0.91%
C: -2.26%
SNY | $46.05 -0.41% 940K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid phase 1 vaccine trial phase 3 phase 2 covid-19
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
BSGM | $1.52 38.18% 3.2M
|
Health Technology
VIAO | $0.2426 -21.23% 230K
|
Electronic Technology
KULR | $0.47 -19.27% 6.4M
|
Manufacturing
BACK | $4.53 35.22% 26.05% 950K
|
Health Care and Social Assistan...
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.